初次全髋关节置换术后异位骨化发生危险因素的识别
该回顾性研究分析了2010年9月至2019年10月在加州大学旧金山医院接受初次全髋关节置换术的2541例患者,术后异位骨化(HO)发生率为3%(n=80)。黑人/非裔美国人种族(OR 2.97)、既存骨质疏松(OR 2.72)、脊柱疾病(OR 2.04)和低雌激素状态(OR 1.99)是HO的显著预测因素;围手术期使用非甾体抗炎药(NSAIDs)与HO形成负相关(OR 0.39)。
要点
- 初次全髋关节置换术后HO发生率为3%(n=80)。
- 黑人/非裔美国人种族、骨质疏松、脊柱疾病和低雌激素状态是HO的显著预测因素。
- 围手术期NSAIDs使用与HO形成负相关(OR 0.39,P=0.001)。
核心结论
- 初次全髋关节置换术后新发现的与HO风险增加可能相关的因素包括黑人/非裔美国人种族、骨质疏松和低雌激素状态;这些患者可能受益于HO预防措施如围手术期NSAIDs。
研究设计与样本
- 回顾性审查2010年9月至2019年10月在加州大学旧金山医院接受髋关节置换术的4070例个体的电子病历,纳入2541例初次髋关节置换术患者进行逻辑回归分析。
主要发现
- 术后HO发生率为3%(n=80);HO组中骨质疏松、维生素D缺乏、脊柱疾病、1型或2型糖尿病、闭经、绝经后状态、甲状旁腺疾病和病理性骨折史的比例更大(P值分别<0.001、<0.001、<0.001、<0.001、0.037、<0.001、0.011、0.005)。
- HO的显著预测因素包括黑人/非裔美国人种族(OR 2.97,P=0.005)、既存骨质疏松(OR 2.72,P=0.001)、脊柱疾病(OR 2.04,P=0.036)和低雌激素状态(OR 1.99,P=0.025)。
- 总体组中75.64%接受围手术期NSAIDs,其与HO形成负相关(OR 0.39,P=0.001)。
临床怎么用
- 作者认为,具有黑人/非裔美国人种族、骨质疏松和低雌激素状态等新发现因素的患者可能受益于HO预防措施如围手术期NSAIDs。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Heterotopic ossification (HO) is a process by which bone forms abnormally in soft tissues. Known risk factors for developing HO include male sex, spinal cord injury, trauma, and surgery. We investigated additional risk factors in the development of HO after hip arthroplasty. METHODS: We performed a retrospective review of electronic medical records of 4070 individuals who underwent hip arthroplasty from September 2010 to October 2019 at the University of California, San Francisco Hospital. Demographics, anthropometrics, medications, and comorbid conditions were used in logistic regression analysis to identify factors associated with the development of HO. RESULTS: A total of 2541 patients underwent primary hip arthroplasty in the analyzed timeframe (46.04% men, mean age at procedure: 62.13 ± 13.29 years). The incidence of postsurgical HO was 3% (n = 80). A larger proportion of individuals who developed HO had underlying osteoporosis (P < 0.001), vitamin D deficiency (P < 0.001), spine disease (P < 0.001), type 1 or 2 diabetes (P < 0.001), amenorrhea (P = 0.037), postmenopausal status (P < 0.001), parathyroid disorders (P = 0.011), and history of pathologic fracture (P = 0.005). Significant predictors for HO development were Black/African American race [odds ratio (OR) 2.97, P = 0.005], preexisting osteoporosis (OR 2.72, P = 0.001), spine disease (OR 2.04, P = 0.036), and low estrogen states (OR 1.99, P = 0.025). In the overall group, 75.64% received perioperative nonsteroidal anti-inflammatory drugs (NSAIDs), which negatively correlated with HO formation (OR 0.39, P = 0.001). CONCLUSIONS: We identified new factors potentially associated with an increased risk of developing HO after primary hip arthroplasty, including African American race, osteoporosis, and low estrogen states. These patients may benefit from HO prophylaxis, such as perioperative NSAIDs.
引用
- Singh S, Morshed S, Motamedi D, et al. Identification of Risk Factors in the Development of Heterotopic Ossification After Primary Total Hip Arthroplasty. J Clin Endocrinol Metab. 2022. PMID: 35451005. doi:10.1210/clinem/dgac249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。